{"count": 9, "results": [{"_id": "34990819", "pmid": 34990819, "title": "Dynamic urine proteome changes in a rat model of simvastatin-induced skeletal muscle injury.", "journal": "J Proteomics", "authors": ["Wei J", "Huan Y", "Heng Z", "Zhao C", "Jia L", "Yu Y", "Gao Y"], "date": "2022-03-15T00:00:00Z", "doi": "10.1016/j.jprot.2021.104477", "meta_date_publication": "2022 Mar 15", "meta_volume": "254", "meta_issue": "", "meta_pages": "104477", "score": 50278.17, "text_hl": "Dynamic urine proteome changes in a @SPECIES_10116 @@@rat@@@ model of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@-induced @<m>DISEASE_Fasciculation</m> @DISEASE_MESH:D005207 @@@skeletal muscle injury@@@.", "citations": {"NLM": "Wei J, Huan Y, Heng Z, Zhao C, Jia L, Yu Y, Gao Y. Dynamic urine proteome changes in a rat model of simvastatin-induced skeletal muscle injury. J Proteomics. 2022 Mar 15;254():104477. PMID: 34990819", "BibTeX": "@article{34990819, title={Dynamic urine proteome changes in a rat model of simvastatin-induced skeletal muscle injury.}, author={Wei J and Huan Y and Heng Z and Zhao C and Jia L and Yu Y and Gao Y}, journal={J Proteomics}, volume={254}, pages={104477}}"}}, {"_id": "31823428", "pmid": 31823428, "title": "Astragaloside IV reverses simvastatin-induced skeletal muscle injury by activating the AMPK-PGC-1alpha signalling pathway.", "journal": "Phytother Res", "authors": ["Jiang B", "Yang YJ", "Dang WZ", "Li H", "Feng GZ", "Yu XC", "Shen XY", "Hu XG"], "date": "2020-05-01T00:00:00Z", "doi": "10.1002/ptr.6593", "meta_date_publication": "2020 May", "meta_volume": "34", "meta_issue": "5", "meta_pages": "1175-1184", "score": 50268.535, "text_hl": "@CHEMICAL_astragaloside_A @CHEMICAL_MESH:C052064 @@@Astragaloside IV@@@ reverses @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@-induced @<m>DISEASE_Fasciculation</m> @DISEASE_MESH:D005207 @@@skeletal muscle injury@@@ by activating the AMPK-@GENE_PPARGC1A @GENE_19017 @@@PGC-1alpha@@@ signalling pathway.", "citations": {"NLM": "Jiang B, Yang YJ, Dang WZ, Li H, Feng GZ, Yu XC, Shen XY, Hu XG. Astragaloside IV reverses simvastatin-induced skeletal muscle injury by activating the AMPK-PGC-1alpha signalling pathway. Phytother Res. 2020 May;34(5):1175-1184. PMID: 31823428", "BibTeX": "@article{31823428, title={Astragaloside IV reverses simvastatin-induced skeletal muscle injury by activating the AMPK-PGC-1alpha signalling pathway.}, author={Jiang B and Yang YJ and Dang WZ and Li H and Feng GZ and Yu XC and Shen XY and Hu XG}, journal={Phytother Res}, volume={34}, number={5}, pages={1175-1184}}"}}, {"_id": "23042107", "pmid": 23042107, "title": "Effect of simvastatin on passive strain-induced skeletal muscle injury in rats.", "journal": "Muscle Nerve", "authors": ["Tomazoni SS", "Leal-Junior EC", "Pallotta RC", "De Godoi V", "Rossi RP", "Frigo L", "Leonardo PS", "De Almeida P", "Lopes-Martins RÁ"], "date": "2012-12-01T00:00:00Z", "doi": "10.1002/mus.23444", "meta_date_publication": "2012 Dec", "meta_volume": "46", "meta_issue": "6", "meta_pages": "908-13", "score": 50082.555, "text_hl": "Effect of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on passive strain-induced @<m>DISEASE_Fasciculation</m> @DISEASE_MESH:D005207 @@@skeletal muscle injury@@@ in @SPECIES_10116 @@@rats@@@.", "citations": {"NLM": "Tomazoni SS, Leal-Junior EC, Pallotta RC, De Godoi V, Rossi RP, Frigo L, Leonardo PS, De Almeida P, Lopes-Martins RÁ. Effect of simvastatin on passive strain-induced skeletal muscle injury in rats. Muscle Nerve. 2012 Dec;46(6):908-13. PMID: 23042107", "BibTeX": "@article{23042107, title={Effect of simvastatin on passive strain-induced skeletal muscle injury in rats.}, author={Tomazoni SS and Leal-Junior EC and Pallotta RC and De Godoi V and Rossi RP and Frigo L and Leonardo PS and De Almeida P and Lopes-Martins RÁ}, journal={Muscle Nerve}, volume={46}, number={6}, pages={908-13}}"}}, {"_id": "25883814", "pmid": 25883814, "pmcid": "PMC4391689", "title": "Severe Rhabdomyolysis Associated with Simvastatin and Role of Ciprofloxacin and Amlodipine Coadministration", "journal": "Case Rep Nephrol", "authors": ["De Schryver N", "Wittebole X", "Van den Bergh P", "Haufroid V", "Goffin E", "Hantson P"], "date": "2015-01-01T00:00:00Z", "doi": "10.1155/2015/761393", "meta_date_publication": "2015", "meta_volume": "2015", "meta_issue": "", "meta_pages": "761393", "score": 50061.17, "text_hl": "...@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ is among the most commonly used prescription medications for @CHEMICAL_Cholesterol @CHEMICAL_MESH:D002784 @@@cholesterol@@@ reduction and the most common statin-related adverse drug reaction is @<m>DISEASE_Fasciculation</m> @DISEASE_MESH:D005207 @@@skeletal muscle toxicity@@@. ", "citations": {"NLM": "De Schryver N, Wittebole X, Van den Bergh P, Haufroid V, Goffin E, Hantson P. Severe Rhabdomyolysis Associated with Simvastatin and Role of Ciprofloxacin and Amlodipine Coadministration Case Rep Nephrol. 2015;2015():761393. PMID: 25883814", "BibTeX": "@article{25883814, title={Severe Rhabdomyolysis Associated with Simvastatin and Role of Ciprofloxacin and Amlodipine Coadministration}, author={De Schryver N and Wittebole X and Van den Bergh P and Haufroid V and Goffin E and Hantson P}, journal={Case Rep Nephrol}, volume={2015}, pages={761393}}"}}, {"_id": "17357590", "pmid": 17357590, "title": "The influence of simvastatin at high dose and diltiazem on myocardium in rabbits, the biochemical study.", "journal": "Acta Pol Pharm", "authors": ["Jasińska M", "Owczarek J", "Orszulak-Michalak D"], "date": "2006-09-01T00:00:00Z", "meta_date_publication": "2006 Sep-Oct", "meta_volume": "63", "meta_issue": "5", "meta_pages": "386-90", "score": 50056.336, "text_hl": "@CHEMICAL_Diltiazem @CHEMICAL_MESH:D004110 @@@Diltiazem@@@ as CYP3A4 inhibitor, is a well recognized risk factor of @<m>DISEASE_Fasciculation</m> @DISEASE_MESH:D005207 @@@skeletal muscles myopathy@@@, if co-administered with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@. ", "citations": {"NLM": "Jasińska M, Owczarek J, Orszulak-Michalak D. The influence of simvastatin at high dose and diltiazem on myocardium in rabbits, the biochemical study. Acta Pol Pharm. 2006 Sep-Oct;63(5):386-90. PMID: 17357590", "BibTeX": "@article{17357590, title={The influence of simvastatin at high dose and diltiazem on myocardium in rabbits, the biochemical study.}, author={Jasińska M and Owczarek J and Orszulak-Michalak D}, journal={Acta Pol Pharm}, volume={63}, number={5}, pages={386-90}}"}}, {"_id": "17257798", "pmid": 17257798, "title": "Simvastatin pretreatment reduces the severity of limb ischemia in an experimental diabetes model.", "journal": "J Vasc Surg", "authors": ["Köksoy C", "Oziş E", "Cakmak A", "Yazgan U", "Okcu-Heper A", "Köksoy A", "Demirpençe E", "Deniz Dinçer U"], "date": "2007-03-01T00:00:00Z", "doi": "10.1016/j.jvs.2006.10.048", "meta_date_publication": "2007 Mar", "meta_volume": "45", "meta_issue": "3", "meta_pages": "590-6", "score": 50053.52, "text_hl": "Furthermore, @<m>DISEASE_Fasciculation</m> @DISEASE_MESH:D005207 @@@skeletal muscle injury@@@, characterized by tissue @DISEASE_Edema @DISEASE_MESH:D004487 @@@edema@@@ and leucosequestration, was significantly less severe with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ pretreatment compared with the nondiabetic animals (P < .01). ", "citations": {"NLM": "Köksoy C, Oziş E, Cakmak A, Yazgan U, Okcu-Heper A, Köksoy A, Demirpençe E, Deniz Dinçer U. Simvastatin pretreatment reduces the severity of limb ischemia in an experimental diabetes model. J Vasc Surg. 2007 Mar;45(3):590-6. PMID: 17257798", "BibTeX": "@article{17257798, title={Simvastatin pretreatment reduces the severity of limb ischemia in an experimental diabetes model.}, author={Köksoy C and Oziş E and Cakmak A and Yazgan U and Okcu-Heper A and Köksoy A and Demirpençe E and Deniz Dinçer U}, journal={J Vasc Surg}, volume={45}, number={3}, pages={590-6}}"}}, {"_id": "30268577", "pmid": 30268577, "title": "Validation of a clinically-relevant rodent model of statin-associated muscle symptoms for use in pharmacological studies.", "journal": "Toxicol Appl Pharmacol", "authors": ["Irwin JC", "Fenning AS", "Ryan KR", "Vella RK"], "date": "2018-12-01T00:00:00Z", "doi": "10.1016/j.taap.2018.09.040", "meta_date_publication": "2018 Dec 1", "meta_volume": "360", "meta_issue": "", "meta_pages": "78-87", "score": 50051.223, "text_hl": "Contrastingly, the SIM50 model (50 mg kg-1 day-1 @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ for 30 days) produced little evidence of significant @<m>DISEASE_Fasciculation</m> @DISEASE_MESH:D005207 @@@skeletal muscle damage@@@. ", "citations": {"NLM": "Irwin JC, Fenning AS, Ryan KR, Vella RK. Validation of a clinically-relevant rodent model of statin-associated muscle symptoms for use in pharmacological studies. Toxicol Appl Pharmacol. 2018 Dec 1;360():78-87. PMID: 30268577", "BibTeX": "@article{30268577, title={Validation of a clinically-relevant rodent model of statin-associated muscle symptoms for use in pharmacological studies.}, author={Irwin JC and Fenning AS and Ryan KR and Vella RK}, journal={Toxicol Appl Pharmacol}, volume={360}, pages={78-87}}"}}, {"_id": "9804052", "pmid": 9804052, "title": "Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in transplant patients: are the statins mechanistically similar?", "journal": "Pharmacol Ther", "authors": ["Christians U", "Jacobsen W", "Floren LC"], "date": "1998-10-01T00:00:00Z", "doi": "10.1016/s0163-7258(98)00016-3", "meta_date_publication": "1998 Oct", "meta_volume": "80", "meta_issue": "1", "meta_pages": "1-34", "score": 50049.715, "text_hl": "Pharmacokinetic interaction with some of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, specifically @CHEMICAL_Lovastatin @CHEMICAL_MESH:D008148 @@@lovastatin@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, leads to an increased incidence of @<m>DISEASE_Fasciculation</m> @DISEASE_MESH:D005207 @@@muscle skeletal toxicity@@@ in transplant @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Christians U, Jacobsen W, Floren LC. Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in transplant patients: are the statins mechanistically similar? Pharmacol Ther. 1998 Oct;80(1):1-34. PMID: 9804052", "BibTeX": "@article{9804052, title={Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in transplant patients: are the statins mechanistically similar?}, author={Christians U and Jacobsen W and Floren LC}, journal={Pharmacol Ther}, volume={80}, number={1}, pages={1-34}}"}}, {"_id": "1904494", "pmid": 1904494, "title": "HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies.", "journal": "J Pharmacol Exp Ther", "authors": ["Smith PF", "Eydelloth RS", "Grossman SJ", "Stubbs RJ", "Schwartz MS", "Germershausen JI", "Vyas KP", "Kari PH", "MacDonald JS"], "date": "1991-06-01T00:00:00Z", "meta_date_publication": "1991 Jun", "meta_volume": "257", "meta_issue": "3", "meta_pages": "1225-35", "score": 50047.58, "text_hl": "In the Sprague-Dawley @SPECIES_10116 @@@rat@@@, very high, pharmacologically comparable dosages (150-1200 mg/kg/day) of structurally similar HMGRIs (@CHEMICAL_Lovastatin @CHEMICAL_MESH:D008148 @@@lovastatin@@@, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, @CHEMICAL_Pravastatin @CHEMICAL_MESH:D017035 @@@pravastatin@@@ and @CHEMICAL_L_647318 @CHEMICAL_MESH:C064146 @@@L-647, 318@@@) produced dose-related increases in the incidence and severity of @<m>DISEASE_Fasciculation</m> @DISEASE_MESH:D005207 @@@skeletal muscle degeneration@@@. ", "citations": {"NLM": "Smith PF, Eydelloth RS, Grossman SJ, Stubbs RJ, Schwartz MS, Germershausen JI, Vyas KP, Kari PH, MacDonald JS. HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies. J Pharmacol Exp Ther. 1991 Jun;257(3):1225-35. PMID: 1904494", "BibTeX": "@article{1904494, title={HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies.}, author={Smith PF and Eydelloth RS and Grossman SJ and Stubbs RJ and Schwartz MS and Germershausen JI and Vyas KP and Kari PH and MacDonald JS}, journal={J Pharmacol Exp Ther}, volume={257}, number={3}, pages={1225-35}}"}}]}